In vivo delivery to tumors of DNA complexed with linear polyethylenimine.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 10428211)

Published in Hum Gene Ther on July 01, 1999

Authors

J L Coll1, P Chollet, E Brambilla, D Desplanques, J P Behr, M Favrot

Author Affiliations

1: Lung Cancer Research Group, Institut Albert Bonniot, Université Joseph Fourier, Grenoble, France.

Articles citing this

A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids. Nucleic Acids Res (2005) 1.81

DNA delivery from matrix metalloproteinase degradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymal stem cells. Biomaterials (2008) 1.14

Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials (2010) 1.03

Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med (2009) 0.95

Utilizing cell-matrix interactions to modulate gene transfer to stem cells inside hyaluronic acid hydrogels. Mol Pharm (2011) 0.93

Polymer-enhanced adenoviral transduction of CAR-negative bladder cancer cells. Mol Pharm (2009) 0.91

Design and characterization of microporous hyaluronic acid hydrogels for in vitro gene transfer to mMSCs. Acta Biomater (2012) 0.89

Generation of a focused poly(amino ether) library: polymer-mediated transgene delivery and gold-nanorod based theranostic systems. Theranostics (2012) 0.89

Discovery of cationic polymers for non-viral gene delivery using combinatorial approaches. Comb Chem High Throughput Screen (2011) 0.89

Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection. Antimicrob Agents Chemother (2011) 0.88

Development of an effective gene delivery system: a study of complexes composed of a peptide-based amphiphilic DNA compaction agent and phospholipid. Nucleic Acids Res (2001) 0.86

Non-viral DNA delivery from porous hyaluronic acid hydrogels in mice. Biomaterials (2014) 0.86

Effective non-viral delivery of siRNA to acute myeloid leukemia cells with lipid-substituted polyethylenimines. PLoS One (2012) 0.83

Development of a reduction-sensitive diselenide-conjugated oligoethylenimine nanoparticulate system as a gene carrier. Int J Nanomedicine (2012) 0.80

Dual-degradable disulfide-containing PEI-Pluronic/DNA polyplexes: transfection efficiency and balancing protection and DNA release. Int J Nanomedicine (2013) 0.78

DNA vaccination for prostate cancer: key concepts and considerations. Cancer Nanotechnol (2015) 0.78

PEI/DNA formation affects transient gene expression in suspension Chinese hamster ovary cells via a one-step transfection process. Cytotechnology (2012) 0.78

Two and three-dimensional gene transfer from enzymatically degradable hydrogel scaffolds. Microsc Res Tech (2010) 0.78

Polyplex Evolution: Understanding Biology, Optimizing Performance. Mol Ther (2017) 0.76

Near-infrared optical imaging of nucleic acid nanocarriers in vivo. Methods Mol Biol (2013) 0.75

Articles by these authors

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A (1995) 18.16

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol (1993) 10.87

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol (2000) 5.20

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol (1988) 4.35

Bidirectional modulation of insulin action by amino acids. J Clin Invest (1998) 2.92

Gene delivery: a single nuclear localization signal peptide is sufficient to carry DNA to the cell nucleus. Proc Natl Acad Sci U S A (1999) 2.58

Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol (1994) 2.21

Coexistence of plasma cell granulomas of lung and central nervous system. Pathol Res Pract (1995) 2.13

Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Arch Ophthalmol (1994) 2.00

Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem (1998) 1.98

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid. J Clin Oncol (1986) 1.98

E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35. Cell Death Differ (2008) 1.95

Chronomodulated versus fixed-infusion-rate delivery of ambulatory chemotherapy with oxaliplatin, fluorouracil, and folinic acid (leucovorin) in patients with colorectal cancer metastases: a randomized multi-institutional trial. J Natl Cancer Inst (1994) 1.92

A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: polyethylenimine. Hum Gene Ther (1996) 1.91

Targeted gene transfer into hepatoma cells with lipopolyamine-condensed DNA particles presenting galactose ligands: a stage toward artificial viruses. Proc Natl Acad Sci U S A (1995) 1.91

Gene transfer with a series of lipophilic DNA-binding molecules. Bioconjug Chem (1995) 1.87

Gene transfer optimization with lipospermine-coated DNA. DNA Cell Biol (1993) 1.78

Comparative pathology of silicate pneumoconiosis. Am J Pathol (1979) 1.76

An electron microscopy study into the mechanism of gene transfer with lipopolyamines. Gene Ther (1996) 1.75

Optimized galenics improve in vitro gene transfer with cationic molecules up to 1000-fold. Gene Ther (1996) 1.74

TUNEL apoptotic cell detection in tissue sections: critical evaluation and improvement. J Histochem Cytochem (1998) 1.73

Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung. Hum Mol Genet (1997) 1.70

Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer (1997) 1.70

Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A (2000) 1.69

Pulmonary inflammatory myofibroblastic tumour with unusual octreoscan uptake: two reports. Eur Respir J (2010) 1.68

Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet (1986) 1.68

An immunohistological approach to persistent lymphadenopathy and its relevance to AIDS. Clin Exp Immunol (1985) 1.64

Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival. J Pathol (1999) 1.63

In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem (1996) 1.60

Neural cell adhesion molecules (NCAM) and NCAM-PSA expression in neuroendocrine lung tumors. Am J Surg Pathol (1998) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique. J Clin Oncol (1997) 1.59

Inflammatory breast cancer. Pilot study of intensive induction chemotherapy (FEC-HD) results in a high histologic response rate. Am J Clin Oncol (1993) 1.58

Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene (2001) 1.55

Canarypox virus-mediated interleukin 12 gene transfer into murine mammary adenocarcinoma induces tumor suppression and long-term antitumoral immunity. Hum Gene Ther (1998) 1.54

DNA methylation profiles of lung tumors. Mol Cancer Ther (2001) 1.53

F(ab) secondary antibodies: a general method for double immunolabeling with primary antisera from the same species. Efficiency control by chemiluminescence. J Histochem Cytochem (1994) 1.48

In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. Bioconjug Chem (1998) 1.45

Prognostic value of initial tumor parameters after metastatic relapse. Cancer Invest (2011) 1.45

Nomenclature for synthetic gene delivery systems. Hum Gene Ther (1997) 1.44

Phase II trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer. J Clin Oncol (2002) 1.44

Primary lung adenocarcinoma: characteristics by smoking habit and sex. Eur Respir J (2011) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

[Bronchiolo-alveolar carcinoma: a new entity]. Rev Mal Respir (2003) 1.38

Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med (2000) 1.34

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial. Ann Oncol (2005) 1.33

Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32

Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma. Oncogene (2001) 1.32

Vasculotropin-VEGF stimulates retinal capillary endothelial cells through an autocrine pathway. Invest Ophthalmol Vis Sci (1994) 1.31

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo. Oncogene (2010) 1.31

Intrathecal delivery of IFN-gamma protects C57BL/6 mice from chronic-progressive experimental autoimmune encephalomyelitis by increasing apoptosis of central nervous system-infiltrating lymphocytes. J Immunol (2001) 1.29

Monomolecular collapse of plasmid DNA into stable virus-like particles. Proc Natl Acad Sci U S A (1998) 1.28

Transfection and physical properties of various saccharide, poly(ethylene glycol), and antibody-derivatized polyethylenimines (PEI). J Gene Med (2000) 1.27

Functional characterization of ATAD2 as a new cancer/testis factor and a predictor of poor prognosis in breast and lung cancers. Oncogene (2010) 1.24

T cell regeneration after allogeneic bone marrow transplantation. Clin Exp Immunol (1983) 1.24

Pulmonary atypical carcinoid: predictors of survival in 106 cases. Hum Pathol (2000) 1.20

Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis. Eur Respir J (2007) 1.18

IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis. Gene Ther (2008) 1.18

High-resolution ghost image and ghost diffraction experiments with thermal light. Phys Rev Lett (2005) 1.17

Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther (1999) 1.17

Detection of sub-shot-noise spatial correlation in high-gain parametric down conversion. Phys Rev Lett (2004) 1.16

Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J (2011) 1.16

Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids. J Gene Med (2001) 1.16

Genetic changes in the spectrum of neuroendocrine lung tumors. Cancer (1999) 1.16

E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors. Oncogene (2007) 1.14

The use of fluoride varnishes in the prevention of dental caries: a short review. Oral Dis (2001) 1.14

Cleavage of tRNA with imidazole and spermine imidazole constructs: a new approach for probing RNA structure. Nucleic Acids Res (1995) 1.13

Altered pattern of Cul-1 protein expression and neddylation in human lung tumours: relationships with CAND1 and cyclin E protein levels. J Pathol (2007) 1.13

High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: long-term results. J Clin Oncol (1997) 1.12

Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours. Br J Cancer (2004) 1.12

Methionine dependency and cancer treatment. Cancer Treat Rev (2003) 1.11

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate. Eur J Cancer (1993) 1.10

Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. J Cell Physiol (1995) 1.10

Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol (2008) 1.10

A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. International Organization for Cancer Chronotherapy. Cancer (1999) 1.09

Thyroid transcription factor 1 and cytokeratins 1, 5, 10, 14 (34betaE12) expression in basaloid and large-cell neuroendocrine carcinomas of the lung. Hum Pathol (2001) 1.09

Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene (1998) 1.09

Ghost imaging with thermal light: comparing entanglement and classical correlation. Phys Rev Lett (2004) 1.08

Agglutination of peripheral blood lymphocytes from cancer patients and not from healthy controls, with the F2A1 histone fraction. Br J Cancer (1975) 1.08

E2F1 induces apoptosis and sensitizes human lung adenocarcinoma cells to death-receptor-mediated apoptosis through specific downregulation of c-FLIP(short). Cell Death Differ (2006) 1.08

Effect of vitamin A on enzymic conversion of the delta-5-3-beta-hydroxy- into delta-4-3-oxosteroids by adrenals of the rat. Am J Clin Nutr (1969) 1.07

The potential role of BAX and BCL-2 expression in diffuse alveolar damage. Am J Pathol (1997) 1.07

Basaloid bronchial carcinoma. A histologic group with a poor prognosis. Cancer (1994) 1.06

ExGen 500 is an efficient vector for gene delivery to lung epithelial cells in vitro and in vivo. Gene Ther (1997) 1.05

Comorbidities and Charlson score in resected stage I nonsmall cell lung cancer. Eur Respir J (2005) 1.04

T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrow. Clin Exp Immunol (1986) 1.04

Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer? Lung Cancer (2005) 1.04

Neoadjuvant chemotherapy in 126 operable breast cancers. Eur J Cancer (1992) 1.04

Importance of DNA fragmentation in apoptosis with regard to TUNEL specificity. Biomed Pharmacother (1998) 1.03

The effect of surface roughness on early in vivo plaque colonization on titanium. J Periodontol (1997) 1.02

Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in culture. Cornea (1997) 1.02

Location of spermine and other polyamines on DNA as revealed by photoaffinity cleavage with polyaminobenzenediazonium salts. Biochemistry (1991) 1.02

Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit. Circulation (2001) 1.01

X entanglement: the nonfactorable spatiotemporal structure of biphoton correlation. Phys Rev Lett (2009) 1.01

Mucinous cystadenoma of the lung. Cancer (1995) 1.00

Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity. Gene Ther (2001) 1.00

New photoactivatable structural and affinity probes of RNAs: specific features and applications for mapping of spermine binding sites in yeast tRNA(Asp) and interaction of this tRNA with yeast aspartyl-tRNA synthetase. Nucleic Acids Res (1990) 1.00

Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer. Eur J Cancer (1997) 1.00